APA (7th ed.) Citation

N, J., K, P., M, G., S, M., A, C., L, N., . . . N, K. (2025). High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide. Blood cell therapy, 8(1), 167. https://doi.org/10.31547/bct-2024-024

Chicago Style (17th ed.) Citation

N, Jindal, et al. "High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide." Blood Cell Therapy 8, no. 1 (2025): 167. https://doi.org/10.31547/bct-2024-024.

MLA (9th ed.) Citation

N, Jindal, et al. "High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide." Blood Cell Therapy, vol. 8, no. 1, 2025, p. 167, https://doi.org/10.31547/bct-2024-024.